Viewing Study NCT03340220


Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2026-03-06 @ 9:17 AM
Study NCT ID: NCT03340220
Status: COMPLETED
Last Update Posted: 2023-05-11
First Post: 2017-10-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101.
Sponsor: Xenon Pharmaceuticals Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module